Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation.

Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation.

An increasing number of investigations including human studies demonstrate that pharmacological ischaemic preconditioning is a viable way to protect the heart from myocardial ischaemia/reperfusion (I/R) injury. This study investigated the role of hydroxychloroquine (HCQ) in the heart during I/R inju...

Full description

Bibliographic Details
Main Authors: Lauren Bourke, James McCormick, Valerie Taylor, Charis Pericleous, Benoit Blanchet, Nathalie Costedoat-Chalumeau, Daniel Stuckey, Mark F Lythgoe, Anastasis Stephanou, Yiannis Ioannou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0143771

Internet

https://doi.org/10.1371/journal.pone.0143771

Similar Items